ArticleCell reports. Medicine2026

CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemia.

Melissa L Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.